FCBT
DGX icon

First Citizens Bank & Trust’s Quest Diagnostics DGX Stock Holding History

First Citizens Bank & Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Buy
3,130
+155
+5% +$30.4K 0.01% 397
2026
Q1 		$583K Sell
2,975
-728
-20% -$141K 0.01% 407
2025
Q4 		$643K Sell
3,703
-1,032
-22% -$188K 0.01% 385
2025
Q3 		$902K Sell
4,735
-314
-6% -$55.7K 0.02% 306
2025
Q2 		$907K Sell
5,049
-595
-11% -$103K 0.02% 300
2025
Q1 		$955K Sell
5,644
-1,850
-25% -$304K 0.02% 244
2024
Q4 		$1.13M Sell
7,494
-1,481
-17% -$230K 0.02% 229
2024
Q3 		$1.39M Sell
8,975
-268
-3% -$40K 0.03% 217
2024
Q2 		$1.27M Sell
9,243
-39,114
-81% -$5.36M 0.02% 225
2024
Q1 		$6.44M Buy
48,357
+14,636
+43% +$1.9M 0.12% 91
2023
Q4 		$4.65M Sell
33,721
-20,818
-38% -$2.74M 0.08% 97
2023
Q3 		$6.65M Sell
54,539
-3,839
-7% -$511K 0.13% 70
2023
Q2 		$8.21M Buy
58,378
+10,988
+23% +$1.51M 0.15% 63
2023
Q1 		$6.7M Buy
47,390
+7,257
+18% +$1.04M 0.13% 63
2022
Q4 		$6.28M Buy
40,133
+5,078
+14% +$730K 0.19% 51
2022
Q3 		$4.3M Sell
35,055
-3,260
-9% -$429K 0.14% 72
2022
Q2 		$5.1M Buy
38,315
+287
+0.8% +$39.1K 0.18% 61
2022
Q1 		$5.21M Buy
38,028
+1,494
+4% +$208K 0.2% 73
2021
Q4 		$6.32M Sell
36,534
-1,933
-5% -$294K 0.25% 58
2021
Q3 		$5.59M Sell
38,467
-607
-2% -$88.8K 0.27% 54
2021
Q2 		$5.16M Sell
39,074
-1,551
-4% -$203K 0.24% 67
2021
Q1 		$5.21M Buy
40,625
+15,470
+61% +$1.91M 0.25% 67
2020
Q4 		$3M Sell
25,155
-2,029
-7% -$247K 0.15% 97
2020
Q3 		$3.11M Sell
27,184
-4,383
-14% -$518K 0.22% 84
2020
Q2 		$3.6M Buy
31,567
+5,003
+19% +$531K 0.3% 82
2020
Q1 		$2.13M Sell
26,564
-225
-0.8% -$23.3K 0.26% 89
2019
Q4 		$2.86M Sell
26,789
-458
-2% -$47.8K 0.28% 85
2019
Q3 		$2.92M Buy
27,247
+367
+1% +$37.7K 0.35% 78
2019
Q2 		$2.74M Buy
26,880
+74
+0.3% +$7.11K 0.3% 85
2019
Q1 		$2.41M Sell
26,806
-297
-1% -$25.7K 0.27% 99
2018
Q4 		$2.26M Sell
27,103
-699
-3% -$65.5K 0.27% 93
2018
Q3 		$3M Buy
27,802
+9,879
+55% +$1.08M 0.33% 76
2018
Q2 		$1.97M Buy
17,923
+456
+3% +$47.5K 0.24% 116
2018
Q1 		$1.75M Sell
17,467
-144
-0.8% -$14.7K 0.24% 122
2017
Q4 		$1.74M Sell
17,611
-3,009
-15% -$285K 0.23% 116
2017
Q3 		$1.93M Sell
20,620
-484
-2% -$51.4K 0.25% 118
2017
Q2 		$2.35M Sell
21,104
-13,736
-39% -$1.45M 0.3% 97
2017
Q1 		$3.42M Buy
+34,840
New +$3.32M 0.41% 73
2013
Q4 		– Sell
-14,887
Closed -$920K – 454
2013
Q3 		$920K Buy
14,887
+220
+1% +$13.2K 0.04% 440
2013
Q2 		$889K Buy
+14,667
New +$874K 0.04% 429

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

First Citizens Bank & Trust's DGX Position: Q2 2026 in Review

First Citizens Bank & Trust increased its Quest Diagnostics (DGX) stake by 5.2% in Q2 2026, buying an estimated $30.4K and bringing the position to 3,130 shares worth $663K. The position accounts for 0.01% of the portfolio, ranked #397.

First Citizens Bank & Trust first reported a position in DGX in Q2 2013 and has held it in 40 quarters since. The position peaked at $8.21M in Q2 2023. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • First Citizens Bank & Trust held 3,130 shares of Quest Diagnostics worth $663K as of Q2 2026.
  • First Citizens Bank & Trust bought 155 Quest Diagnostics shares in Q2 2026, an estimated $30.4K.
  • Quest Diagnostics made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #397 holding.
  • First Citizens Bank & Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 40 quarters since.
  • First Citizens Bank & Trust's Quest Diagnostics position peaked at $8.21M in Q2 2023.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.